A Retrospective Study of Blinatumomab Based Salvage Regimen as a Bridge to Allogeneic Hematopoietic Cell Transplantation (HCT) for Patients With Relapsed and Refractory ALL
Biology of Blood and Marrow Transplantation - Netherlands
doi 10.1016/j.bbmt.2018.12.371
Full Text
Open PDFAbstract
Available in full text
Date
March 1, 2019
Authors
Publisher
Elsevier BV